Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants

By Longworth E.   Borrow R.   Goldblatt D.   Balmer P.   Dawson M.   Andrews N.   Miller E.   Cartwright K.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2592-2596

Elsevier

Access to resources Recommend Favorite

Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine

By Martin S.L.   Borrow R.   van der Ley P.   Dawson M.   Fox A.J.   Cartwright K.A.V.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2476-2481

Elsevier

Access to resources Recommend Favorite

Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine

By Meyer Naess L.   Aarvak T.   Aase A.   Oftung F.   Hoiby E.A.   Sandin R.   Michaelsen T.E.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 754-764

Elsevier

Access to resources Recommend Favorite

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

By Peeters C.C.A.M.   Rumke H.C.   Sundermann L.C.   van der Voort E.M.R.   Meulenbelt J.   Schuller M.   Kuipers A.J.   van der Ley P.   Poolman J.T.  

Vaccine, Vol. 14, Iss. 10, 1996-07 ,pp. : 1009-1015

Elsevier

Access to resources Recommend Favorite

Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines

By Robin G.   Keisari Y.   Slepon R.   Ashkenazi S.   Cohen D.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3109-3115

Elsevier

Access to resources Recommend Favorite